Nano-X Imaging (NNOX): A $17M factory write-off & the med-tech waiting game [Q4 2025]

Nano-X Imaging's Q4 2025 was a stark reality check, anchored by a massive $17.5 million impairment charge that highlights the painful gap between medical hardware ambition and actual commercial scale.In ~10 minutes:• Why management finally pulled the plug on their South Korean chip fab• How the Vaso Health IT acquisition bought instant software revenue• The bureaucratic bottlenecks pushing the hardware ramp to late 2026• Why the market handed the stock a brutal 24% gap-down 📉While teleradiology revenues flatlined at $3.1M, the decision to outsource semiconductor manufacturing to Switzerland stops the bleeding from a misguided COVID-era factory build. But with hospital installations still crawling, investors are being asked to endure another painful waiting game to see if the promised deployment momentum arrives.Nano-X Imaging (NNOX) | Q4 FY2025AI-assisted production. Feedback/ticker requests: https://x.com/EarnUnscripted.